CONSTELLA
CONSTELLA
Approved
DIN Number
02469510
Drug Class
Human
Market Date
Apr 2, 2018
Company
HC
Abbvie Corporation
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02469510
AIG Number0155070003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
A06AX04 LINACLOTIDE
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification56:92.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
LINACLOTIDEActive
Strength: 72 MCG
Monograph: LINACLOTIDE